标题
The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume 12, Issue 5, Pages 321-337
出版商
Springer Nature
发表日期
2011-10-05
DOI
10.2165/11587890-000000000-00000
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
- (2011) Bruce E. Strober et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: A systematic review and meta-analysis of randomized controlled trials
- (2011) Erica D. Dommasch et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis
- (2010) Alexa Boer Kimball et al. AMERICAN JOURNAL OF MEDICINE
- Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet
- (2010) Craig Leonardi et al. ARCHIVES OF DERMATOLOGY
- Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
- (2010) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.
- (2010) K Abuabara et al. BRITISH JOURNAL OF DERMATOLOGY
- A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study
- (2010) D. Thaçi et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy
- (2010) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
- (2010) Akihiko ASAHINA et al. JOURNAL OF DERMATOLOGY
- Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
- (2009) G R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of Psoriasis With Coronary Artery, Cerebrovascular, and Peripheral Vascular Diseases and Mortality
- (2009) Srjdan Prodanovich et al. ARCHIVES OF DERMATOLOGY
- Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database
- (2009) N. N. Mehta et al. EUROPEAN HEART JOURNAL
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis
- (2008) Judith M. Dalrymple et al. ARTHRITIS AND RHEUMATISM
- Long-term data in the treatment of psoriasis
- (2008) D. Thaçi BRITISH JOURNAL OF DERMATOLOGY
- Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
- (2007) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started